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SWINE PLASMA IMMUNOGLOBULINS FOR PREVENTION AND 
TREATMENT OF POST-WEANING DIARRHOEA: OPTIMIZING 
STABILITY TOWARDS GUT CONDITIONS
Background
Materials & Methods
Immunoglobulin isolation:
Aim
Figure 3.
Conclusions
Post-weaning diarrhoea (PWD) is a common condition in intensive swine
production, resulting in reduced welfare of weaners and economic losses
for the farmer as a result of illness, death, treatment costs, e.g. high
consumption of antibiotics and zinc oxide.
1. Developing feed additives for oral provision for protection
against PWD based on natural antibodies (immunoglobulins)
derived directly from inexpensive raw materials.
2. To increase stability (reducing gut proteolysis) by cross-
linking the immunoglobulins (Igs).
ELISA:
In vitro gut conditions:
Figure 1: Sodium Periodate (NaIO4) multimerisation
Figure 2. 
A:
Results
A ‘Sandwich ELISA’ was applied to observe the reactivity of the purified
Igs used as the ‘bottom’ antibody. Extract of Serotype O149 E.coli was
used as antigen and a biotinylated rabbit anti-E.coli (AbD Serotec) was
used as ‘top’ antibody.
Figure 1. Carbohydrates on immunoglobulins, comprise diols (in red), which are cleavable by the periodate generating
aldehydes that in turn can bind to free amines on the polypeptide chain of other immunoglobulins.
Porcine Igs and 1000 units/ml pepsin were incubated in 50mM sodium
acetate pH 3 for 3 hrs. at 37C whereafter the pepsin was inactivated by
adding Na2CO3 buffer that increased pH to 9.6.
Next one pepsin treated sample was chosen (pH 9, 0 mM NaIO4), which
then was treated either with trypsin, chymotrypsin or with both.
Both proteases were titrated ranging from 887-0.05 u/ml trypsin and
127-0.007 u/ml chymotrypsin. Incubation for 2 hrs. at 37C. The
proteolytical reaction was stopped by addition of the Pefabloc® inhibitor
(Sigma-Aldrich).
Figure 2. (A): Immunoglobulin-multimerisation carried out at different pH and periodate concentrations (coloured lines) as
compared to non-periodate aggregates (black line) on Sephacryl S300 gelfiltration. (B): The samples (grouped by pH of cross-
coupling reaction) visualised by Silver stained non-reduced SDS PAGE. From left the non-cross-coupled Igs; then Igs
multimerised at 10mM to 40 mM NaIO4 either without or with 1000 unit pepsin.
Porcine Igs were purified from blood plasma at UpFront Chromatography
A/S (Copenhagen) by high-volume Expanded Bed Adsorption with a
proprietary adsorbent. Plasma was obtained from a Danish slaughter
house. The immunoglobulins were multimerised by controlled periodate
oxidation of immunoglobulin-bound carbohydrate (Fig. 1). The
multimerisation process was stopped by increasing pH to 12. Cross-
coupled Ig-species were analysed by gel filtration using a S300 Sephacryl
column and non-reduced 12% Bis-Tris SDS PAGE.
The degree of Igs-multimerisation was tested at 10, 20 and 40 mM
NaIO4 and at different pH values. At low to neutral pH, a tendency
towards spontaneous aggregation was observed as these Ig species were
eluting early from the gel filtration column (Fig. 2A, pH 6-7) and appear
as a high molecular smear on SDS PAGE (Fig. 2B, pH 6-7); in contrast,
Igs cross-linked at pH 9 eluted in response to the degree of NaIO4
concentration resulting in a transition from right to left on the
chromatographs (Fig. 2A, pH 9) due to the increase in size of the
multimers (Fig. 2B, pH 9).
B:
• The optimal conditions for the Igs were observed to  be a 
moderate multimerisation at pH 9, which confers better 
pepsin-resistance and increased reactivity towards E. coli 
O149.
• These results suggest that cross-linked Igs could be used for 
prevention/treatment of PWD and reduce antibiotic 
consumption.
In general, pepsin degraded the porcine Igs extensively (Fig. 2B, pepsin)
and especially Igs that had been subjected to periodate oxidation at
low/neutral pH conditions were less stabile in the presence of pepsin than
those samples that had been periodate treated at pH 9. Furthermore,
greater multimerisation also resulted in lower stability (Fig. 2B, pepsin).
Periodate-induced porcine Ig multimerisation carried out at low to neutral
pH or at high periodate concentrations (20 and 40 mM) did not favour E.
coli reactivity (Figure 3A) in comparison to periodate oxidation done at 10
mM and pH 9, which on the contrary increased Ig-reactivity towards E. coli
(Figure 3A, 10 mM).
Digestion of the pepsin-treated ‘pH 9 sample’ with trypsin and
chymotrypsin revealed that trypsin, in contrast to chymotrypsin, does not
digest the F(ab’)2 well (Fig. 3B).
IMMUNOGLOBULIN MULTIMERISATION:
GUT CONDITIONS:
Figure 3. Protease digestions of the porcine Igs. (A): After cross-coupling (green) and pepsin digestion (red) these Igs
were used as the bottom antibodies in a sandwich ELISA. Lysate from serotype O149 E. coli was used as antigens and a
biotinylated rabbit anti-E. coli antibody was used as top antibody/for development. (B): Three-fold titration of trypsin or
chymotrypsin alone or both proteases together on the pepsin treated non-multimerised pH 9 sample (see fig. 2B, arrow).
Trypsin ranged from 887 to 0.05 u/ml and chymotrypsin from 127 to 0.007 u/ml.
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